CYTK NASDAQ
Cytokinetics, Incorporated
1W: -0.7%
1M: +17.8%
3M: +14.9%
YTD: +26.4%
1Y: +139.0%
3Y: +109.7%
5Y: +201.0%
$76.94
-1.12 (-1.43%)
Weekly Expected Move ±10.8%
$60
$68
$76
$84
$92
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$106M
Revenue
+450.6% YoY
$-830M
Net Income
-34.8% YoY
$-549M
Free Cash Flow
-34.1% YoY
87.6%
Gross Margin
-948.7%
Op. Margin
-1064.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE208.7%
ROA-58.7%
ROIC196.3%
Valuation
P/E-11.4
P/B-11.5
EV/EBITDA-11.4
Leverage
Debt/Equity-1.95
Current Ratio4.53
Interest Cov.-6.6x
Quality Scores
Piotroski F4/9
Altman Z-2.16
Beneish M-31.72